对人类衰老的药理干预措施
Michael Angelo Petr1, Frida Matiyevskaya1, Brenna Osborne1
1Center for Healthy Aging, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen 2200, Denmark.
Ageing research reviews
|February 3, 2024
概括
本综述总结了136项针对药理干预的与年龄相关疾病的临床试验. 一个新的数据库,AgingDB,集中了这些试验及其结果的信息,以便更容易访问.
科学领域:
- 老年病学和药理学
- 临床试验分析
背景情况:
- 与年龄相关的疾病对健康构成重大挑战.
- 药理干预是减轻衰老的关键研究领域.
- 目前,关于老化临床试验的信息是分散的.
研究的目的:
- 巩固和审查现有的临床试验,重点是针对衰老的药理干预.
- 创建一个集中,可搜索的数据库 (AgingDB) 的这些试验.
- 提供针对人类衰老的当前药理学策略的概述.
主要方法:
- 对136项已完成或正在进行的临床试验进行系统审查.
- 开发一个全面的数据库 (AgingDB),详细介绍试验信息和结果.
- 在衰老研究中对药理干预措施的数据收集和分析.
主要成果:
- 总结了136项与衰老和药理学相关的临床试验的数据.
- 建立了AgingDB (www.agingdb.com) 作为追踪试验的资源.
- 确定了针对人类衰老的现有药理学策略.
结论:
- 药理干预措施显示出缓解与年龄相关疾病的前景.
- AgingDB数据库为研究人员和感兴趣的个人提供了有价值的集中资源.
- 这项工作提供了对衰老研究中的药理学景观的全面概述.
相关概念视频
Aging
51
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
51
Alzheimer's Disease: Treatment
193
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
193
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
431
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
62
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
62
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
675
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
675


